Your search returned 41 results.

Results
	1.	Two dimensions in targeting HER2. [electronic resource] by Moasser, Mark M Producer: 20140815 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	HER-2-directed, small-molecule antagonists. [electronic resource] by Arkin, Michelle Moasser, Mark M Producer: 20090209 In: Current opinion in investigational drugs (London, England : 2000) vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	3.	S-phase inhibition of cell cycle progression by a novel class of pyridopyrimidine tyrosine kinase inhibitors. [electronic resource] by Mizenina, Olga A Moasser, Mark M Producer: 20050502 In: Cell cycle (Georgetown, Tex.) vol. 3 Availability: No items available. Save to lists Add to cart (remove)
	4.	The HER family and cancer: emerging molecular mechanisms and therapeutic targets. [electronic resource] by Sergina, Natalia V Moasser, Mark M Producer: 20080312 In: Trends in molecular medicine vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired. [electronic resource] by Chien, A Jo Moasser, Mark M Producer: 20080520 In: Seminars in oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	HER Targeting in HER2-Negative Breast Cancers: Looking for the HER3 Positive. [electronic resource] by Campbell, Marcia R Moasser, Mark M Producer: 20160420 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	The Evolving Landscape of HER2 Targeting in Breast Cancer. [electronic resource] by Moasser, Mark M Krop, Ian E Producer: 20160329 In: JAMA oncology vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Targeting HER2 by Combination Therapies. [electronic resource] by Ruiz-Saenz, Ana Moasser, Mark M Producer: 20190717 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	RETRACTED: An ATP-competitive inhibitor modulates the allosteric function of the HER3 pseudokinase. [electronic resource] by Littlefield, Peter Moasser, Mark M Jura, Natalia Producer: 20150303 In: Chemistry & biology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Retraction Notice to: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase. [electronic resource] by Littlefield, Peter Moasser, Mark M Jura, Natalia Publication details: Cell chemical biology 07 2017 In: Cell chemical biology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy. [electronic resource] by Campbell, Marcia R Amin, Dhara Moasser, Mark M Producer: 20100520 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state. [electronic resource] by Spassov, Danislav S Wong, Ching H Moasser, Mark M Producer: 20110831 In: Cell cycle (Georgetown, Tex.) vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics. [electronic resource] by Amin, Dhara N Campbell, Marcia R Moasser, Mark M Producer: 20110118 In: Seminars in cell & developmental biology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers. [electronic resource] by Amin, Dhara N Ahuja, Deepika Yaswen, Paul Moasser, Mark M Producer: 20160920 In: Molecular cancer therapeutics vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. [electronic resource] by She, Qing-Bai Solit, David Basso, Andrea Moasser, Mark M Producer: 20040520 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	16.	The structural features of Trask that mediate its anti-adhesive functions. [electronic resource] by Spassov, Danislav S Ahuja, Deepika Wong, Ching Hang Moasser, Mark M Producer: 20111128 In: PloS one vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	A Dimerization Function in the Intrinsically Disordered N-Terminal Region of Src. [electronic resource] by Spassov, Danislav S Ruiz-Saenz, Ana Piple, Amit Moasser, Mark M Producer: 20191218 In: Cell reports vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib. [electronic resource] by Amin, Dhara N Ruiz-Saenz, Ana Gulizia, Nathaniel Moasser, Mark M Producer: 20160928 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells. [electronic resource] by Amin, Dhara N Sergina, Natalia Lim, Lionel Goga, Andrei Moasser, Mark M Producer: 20121228 In: The Biochemical journal vol. 447 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation. [electronic resource] by Spassov, Danislav S Baehner, Frederick L Wong, Ching Hang McDonough, Stephen Moasser, Mark M Producer: 20090519 In: The American journal of pathology vol. 174 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 41 results.